A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
All subjects completing the randomized treatment period in Protocol NS2014-1 will discontinue
study drug and be asked to provide consent to be followed in this 6-month study, at their
final safety visit. The study will consist of an enrollment visit, followed by bi-monthly
in-clinic visits with monthly telephone visits between in-clinic visits.